Familial early-onset obesity in Turkish children: variants and polymorphisms in the melanocortin-4 receptor (MC4R) gene. 2022

Heves Kırmızıbekmez, and Yasemin Kendir Demirkol, and Özlem Akgün Doğan, and Gülcan Seymen, and Elif İnan Balcı, and Pınar Atla, and Fatma Dursun
Department of Pediatric Endocrinology, University of Health Sciences, Ümraniye Training and Research Hospital, Istanbul, Turkey.

OBJECTIVE Genetic factors have a key role in childhood obesity with higher rates in children than adults. Among the monogenic types of non-syndromic obesity, melanocortin-4 receptor (MC4R) deficiency is the most frequent cause. Beside pathogenic variants, single-nucleotide polymorphisms in MC4R gene are also associated with lower energy expenditure. The aim of this study was to estimate the frequency of MC4R variants and polymorphisms in a cohort of Turkish children and adolescents with severe early-onset obesity, and to understand the clinical features of patients. METHODS Patients, 1-17 years of age, with the onset of obesity before 10 years of age and a body mass index (BMI) standard deviation score (SDS) of >2.3, and who had a family history of early-onset obesity in at least one of their first-degree relatives were included in the study. Beside routine blood tests genetic analyses for MC4R gene were performed. RESULTS Analyses of MC4R revealed previously known variations in three (3.5%) patients, and pathogenic polymorphisms related with obesity in four (4.7%) patients. BMI SDS values were between 2.8 and 5.5 SDS in the pathogenic variant carrier group, and 2.8-4.9 SDS in the polymorphism group. Mean BMI SDS in variant-negative group was 3.4 ± 0.82. CONCLUSIONS Investigation of the MC4R in individuals with early-onset obesity and presence of obesity first-degree relatives is important. Hypertension is a rare comorbidity compared to other causes. Contrary to studies reporting that insulin resistance was absent or very rare, we found it as a frequent finding in both pathogenic variants and polymorphisms of MC4R.

UI MeSH Term Description Entries
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D005820 Genetic Testing Detection of a MUTATION; GENOTYPE; KARYOTYPE; or specific ALLELES associated with genetic traits, heritable diseases, or predisposition to a disease, or that may lead to the disease in descendants. It includes prenatal genetic testing. Genetic Predisposition Testing,Genetic Screening,Predictive Genetic Testing,Predictive Testing, Genetic,Testing, Genetic Predisposition,Genetic Predictive Testing,Genetic Screenings,Genetic Testing, Predictive,Predisposition Testing, Genetic,Screening, Genetic,Screenings, Genetic,Testing, Genetic,Testing, Genetic Predictive,Testing, Predictive Genetic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D015992 Body Mass Index An indicator of body density as determined by the relationship of BODY WEIGHT to BODY HEIGHT. BMI Quetelet Index,Quetelet's Index,Index, Body Mass,Index, Quetelet,Quetelets Index
D044105 Receptor, Melanocortin, Type 4 A melanocortin receptor subtype found primarily in BRAIN. It shows specificity for ALPHA-MSH; BETA-MSH and ADRENOCORTICOTROPIC HORMONE. Melanocortin Receptor 4,MC4 Receptor,Melanocortin 4 Receptor,Melanocortin-4 Receptor,Receptor, Melanocortin-4,Receptor 4, Melanocortin,Receptor, MC4,Receptor, Melanocortin 4
D020641 Polymorphism, Single Nucleotide A single nucleotide variation in a genetic sequence that occurs at appreciable frequency in the population. SNPs,Single Nucleotide Polymorphism,Nucleotide Polymorphism, Single,Nucleotide Polymorphisms, Single,Polymorphisms, Single Nucleotide,Single Nucleotide Polymorphisms
D063766 Pediatric Obesity BODY MASS INDEX in children (ages 2-12) and in adolescents (ages 13-18) that is grossly above the recommended cut-off for a specific age and sex. For infants less than 2 years of age, obesity is determined based on standard weight-for-length percentile measures. Childhood Obesity,Adolescent Obesity,Adolescent Overweight,Child Obesity,Childhood Onset Obesity,Childhood Overweight,Infant Obesity,Infant Overweight,Infantile Obesity,Obesity in Adolescence,Obesity in Childhood,Obesity, Adolescent,Obesity, Child,Obesity, Childhood,Obesity, Childhood Onset,Obesity, Infant,Obesity, Infantile,Obesity, Pediatric,Overweight, Adolescent,Overweight, Childhood,Overweight, Infant

Related Publications

Heves Kırmızıbekmez, and Yasemin Kendir Demirkol, and Özlem Akgün Doğan, and Gülcan Seymen, and Elif İnan Balcı, and Pınar Atla, and Fatma Dursun
September 2020, European journal of pediatrics,
Heves Kırmızıbekmez, and Yasemin Kendir Demirkol, and Özlem Akgün Doğan, and Gülcan Seymen, and Elif İnan Balcı, and Pınar Atla, and Fatma Dursun
May 2002, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity,
Heves Kırmızıbekmez, and Yasemin Kendir Demirkol, and Özlem Akgün Doğan, and Gülcan Seymen, and Elif İnan Balcı, and Pınar Atla, and Fatma Dursun
January 2007, Zhonghua yi xue za zhi,
Heves Kırmızıbekmez, and Yasemin Kendir Demirkol, and Özlem Akgün Doğan, and Gülcan Seymen, and Elif İnan Balcı, and Pınar Atla, and Fatma Dursun
July 2001, The Journal of clinical endocrinology and metabolism,
Heves Kırmızıbekmez, and Yasemin Kendir Demirkol, and Özlem Akgün Doğan, and Gülcan Seymen, and Elif İnan Balcı, and Pınar Atla, and Fatma Dursun
July 2006, Journal of medicinal chemistry,
Heves Kırmızıbekmez, and Yasemin Kendir Demirkol, and Özlem Akgün Doğan, and Gülcan Seymen, and Elif İnan Balcı, and Pınar Atla, and Fatma Dursun
January 2016, Molecular genetics & genomic medicine,
Heves Kırmızıbekmez, and Yasemin Kendir Demirkol, and Özlem Akgün Doğan, and Gülcan Seymen, and Elif İnan Balcı, and Pınar Atla, and Fatma Dursun
February 2011, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis,
Heves Kırmızıbekmez, and Yasemin Kendir Demirkol, and Özlem Akgün Doğan, and Gülcan Seymen, and Elif İnan Balcı, and Pınar Atla, and Fatma Dursun
September 2020, Physiological research,
Heves Kırmızıbekmez, and Yasemin Kendir Demirkol, and Özlem Akgün Doğan, and Gülcan Seymen, and Elif İnan Balcı, and Pınar Atla, and Fatma Dursun
April 2010, The Journal of nutrition,
Heves Kırmızıbekmez, and Yasemin Kendir Demirkol, and Özlem Akgün Doğan, and Gülcan Seymen, and Elif İnan Balcı, and Pınar Atla, and Fatma Dursun
October 2002, Diabetes research and clinical practice,
Copied contents to your clipboard!